Incyte (INCY) Revenue — Quarter Ended Mar 31, 2025
Revenue for the quarter declined from the immediately preceding quarter but rose compared to the same quarter a year earlier. The sequential decrease contrasts with the prior year's growth, reflecting a mixed quarterly performance.
Key takeaway
Quarter ended Mar 31, 2025 · FY2025 Q1
Revenue for the quarter declined from the immediately preceding quarter but rose compared to the same quarter a year earlier. The sequential decrease contrasts with the prior year's growth, reflecting a mixed quarterly performance.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$1.1B
Revenue reported for this quarter.
Quarter-over-quarter
-10.7%
Change from the immediately preceding quarter.
Year-over-year
+19.5%
Change from the comparable year-ago quarter.
Trailing four quarters
$4.4B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2024 | $1B | +9.3% |
| Sep 30, 2024 | $1.1B | +23.8% |
| Dec 31, 2024 | $1.2B | +16.3% |
| Mar 31, 2025 | $1.1B | +19.5% |
Revenue performance
The reported revenue for the quarter was lower than the prior quarter, yet higher than the same period last year. This pattern indicates a temporary pullback following a period of strong year-over-year gains.
Quarterly comparison
Compared to the preceding quarter, revenue decreased, breaking a streak of sequential increases seen in the prior several quarters. However, relative to the same quarter one year earlier, revenue remained higher, continuing the year-over-year growth trend.
What to watch
The filing discusses ongoing patent challenges and potential generic competition for a key product, which could affect future revenue streams.